home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Seagen Inc. - Common Stock (NQ:SGEN)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Seagen Inc. - Common Stock

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Merck's Buyout Of Seagen Hits Speed Braker Over Price Agreement: Report ↗

August 26, 2022

Via Benzinga

Why Micro Focus International Is Trading Higher By Around 94%; Here Are 28 Stocks Moving Premarket ↗

August 26, 2022

Gainers

Via Benzinga

Roche's Polivy Combo Regime Under FDA Review For Type Of Blood Cancer ↗

August 16, 2022

Via Benzinga

3 Top Stocks to Invest In Right Now ↗

August 16, 2022

Every investor is looking for the top stocks to invest in. These three options will provide you with both offense and defense.

Via InvestorPlace

Seagen Q2 Earnings - Better Than Expected, Mum On M&A, Lifts Outlook ↗

July 29, 2022

Via Benzinga

Seagen Crushes Quarterly Forecasts With Narrower-Than-Expected Losses ↗

July 28, 2022

Merck is reportedly considering a Seagen buyout. But there are a few boxes to tick.

Via Investor's Business Daily

Seagen's Bladder Cancer Trial Data Meets Expectation, Analysts Say ↗

July 26, 2022

Via Benzinga

Seagen For Sale? This Acquisition Target Is 'Too Intriguing To Ignore,' RBC Says ↗

August 16, 2022

The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.”

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 16, 2022 ↗

August 16, 2022

Via Benzinga

U.S. Stock Futures Edge Lower Ahead Of Walmart, Home Depot Earnings ↗

August 16, 2022

Pre-open movers

Via Benzinga

Expert Ratings for Seagen ↗

August 15, 2022

Over the past 3 months, 10 analysts have published their opinion on Seagen (NASDAQ:SGEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

This Analyst Boosts Price Target On Dillard's; Also Check Out Some Other Big PT Changes ↗

August 15, 2022

JP Morgan raised the price target for Dillard's, Inc. (NYSE: DDS) from $210 to $298. Dillard's shares rose 0.9% to $304.42 in pre-market trading.

Via Benzinga

Seagen Suffers Loss In Arbitration Dispute Over ADC Technology ↗

August 15, 2022

Via Benzinga

Does Merck Finally Have The Fodder It Needs To Buy Seagen? ↗

August 12, 2022

The final piece ahead of a potential Seagen buyout took place Friday and shares rose.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Seagen Statement on Outcome of Daiichi Sankyo Arbitration

August 12, 2022

From Seagen Inc.

Via Business Wire

Seattle Genetics's Return On Capital Employed Overview ↗

August 04, 2022

According to Benzinga Pro data, during Q2, Seattle Genetics (NASDAQ:SGEN) posted sales of $497.50 million. Earnings were up 1.22%, but Seattle Genetics still reported an overall loss of $134.83...

Via Benzinga

Recap: Seagen Q2 Earnings ↗

July 28, 2022

Seagen (NASDAQ:SGEN) reported its Q2 earnings results on Thursday, July 28, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Seagen beat estimated earnings by...

Via Benzinga

Seagen Reports Second Quarter 2022 Financial Results

July 28, 2022

From Seagen Inc.

Via Business Wire

7 Stocks to Buy on the Dip ↗

July 28, 2022

There are many stocks to buy on the dip that look to have lost as much as they will and rebound sometime soon.

Via InvestorPlace

The 3 Best Market Sectors for the Second Half of 2022 ↗

July 27, 2022

Compelling themes will drive a recovery in some sectors over the second half of 2022. The following are the best market sectors to buy into.

Via InvestorPlace

Earnings Scheduled For July 28, 2022 ↗

July 28, 2022

Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter.

Via Benzinga

Analyst Ratings for Seagen ↗

July 27, 2022

Over the past 3 months, 9 analysts have published their opinion on Seagen (NASDAQ:SGEN) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's...

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End of The Day Summary ↗

July 26, 2022

Via Benzinga

Seagen Tips Its Hand In Bladder Cancer, But Is It Enough To Woo Merck? ↗

July 26, 2022

One analyst says the study is a "checks-the-box" event for Seagen's potential buyout.

Via Investor's Business Daily

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗

July 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Alibaba, General Electric And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

July 26, 2022

Redbox Entertainment Inc. (NASDAQ: RDBX) rose 11.5% to $6.19 in pre-market trading after jumping 82% on Monday.

Via Benzinga

Seagen Shares Jump On Positive Data From Urothelial Cancer Trial ↗

July 26, 2022

Via Benzinga

Seagen and Astellas Announce Positive Topline Results For PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) as First-Line Treatment for Advanced Urothelial Cancer

July 26, 2022

From Seagen Inc.

Via Business Wire

Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday ↗

July 19, 2022

Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share.

Via Benzinga

< Previous 1 2

...

11 12 13 14 15 16 17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com